US Patent 11691971 Naphthyridinone compounds as JAK2 V617F inhibitors
Patent 11691971 was granted and assigned to Incyte on July, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Jul, 2023
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+188 characters)
US Patent 11691971 Naphthyridinone compounds as JAK2 V617F inhibitors
Article
The present application provides naphthyridinone compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116919710
Date of Patent
July 4, 2023
0Patent Application Number
173504700
Date Filed
June 17, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11691971 Naphthyridinone compounds as JAK2 V617F inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
